Perhaps NUGX is at the crux of the 10-Ks delay.

Perhaps NUGX is at the crux of the 10-Ks delay.

The total NuGenerex outstanding shares must be tabulated on the NGIO 10-K
There are NUGX shares masquerading as NGIO shares, how many? Are there fake shares?
GNBT owns NuGenerex shares (NGIO), what is the true percentage/value?
NGIO valuation must be included in the GNBT 10-K

All this should/must be sorted out with no ambiguity for the end of year audit in order that when the NuGenerex IPO is offered it will be clean.

New Class B IPO shares will be offered/sold.
Old currently issued NuGenerex share converted to Class A shares.
There should be no confusion or legal repercussions about NUGX shares on ownership or legitimacy.
GNBT ownership and valuation of NuGenerex (NGIO) solidified.

If the 10-Ks do not have all their “Ts crossed and Is dotted”, then any future corporate actions could end up in a continual and potential greater mess than it already is.

To get to the “promised land” a bridge must be built, IPO and GNBT up-listing. It would be better to be patient and have the have it (bridge) built solidly than done “half-assed” and have it collapse in the middle of crossing it.

Just my take.